LIMINAL BIOSCIENCES
Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.
LIMINAL BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical
Founded:
1992-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.liminalbiosciences.com
Total Employee:
251+
Status:
Active
Contact:
1(450)781-0115
Email Addresses:
[email protected]
Total Funding:
147.81 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Nginx Euro Amazon Google Maps COVID-19 Amazon Virginia Region DigiCert SSL IIS 10
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-17 | Fairhaven Pharmaceuticals | Fairhaven Pharmaceuticals acquired by Liminal BioSciences | 8 M USD |
| 2016-08-24 | Telesta Therapeutics | Telesta Therapeutics acquired by Liminal BioSciences | N/A |
| 2008-09-04 | Pathogen Removal and Diagnostic Technologies | Pathogen Removal and Diagnostic Technologies acquired by Liminal BioSciences | N/A |
Investors List
National Bank Financial
National Bank Financial investment in Private Equity Round - Liminal BioSciences
Beacon Securities
Beacon Securities investment in Private Equity Round - Liminal BioSciences
Scotiabank
Scotiabank investment in Private Equity Round - Liminal BioSciences
RBC Capital Markets
RBC Capital Markets investment in Private Equity Round - Liminal BioSciences
Paradigm Capital
Paradigm Capital investment in Private Equity Round - Liminal BioSciences
CIBC World Markets
CIBC World Markets investment in Private Equity Round - Liminal BioSciences
Canaccord Genuity Group
Canaccord Genuity Group investment in Private Equity Round - Liminal BioSciences
Jefferies
Jefferies investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Equity - Liminal BioSciences
Newest Events participated
Participated in BioProduction Congress 2017
on 2017-10-17 as exhibitor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as exhibitor
Official Site Inspections
http://www.liminalbiosciences.com Semrush global rank: 6.9 M Semrush visits lastest month: 705
- Host name: ip253.ip-54-38-212.eu
- IP address: 54.38.212.253
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Liminal BioSciences"
Liminal BioSciences - About Us
Liminal BioSciences is a development-stage biopharmaceutical company focused on discovering and developing novel and distinctive small molecule therapeutics that modulate G protein …See details»
Liminal BioSciences - Wikipedia
• Liminal was founded in 1988, as a commercial spinoff of research at the University of Cambridge on affinity chromatography. Its founder was the current President and CEO, Pierre Laurin, whose research formed the basis for the company's products. Liminal was incorporated on October 14, 1994 under the Canada Business Corporations Act, or the CBCA, under the name Innovon Life Sciences Holdings Limited.See details»
Liminal BioSciences - LinkedIn
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled ...See details»
Liminal BioSciences - Crunchbase Company Profile
Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.See details»
Contact - Liminal BioSciences
Liminal BioSciences Inc. (Canada) 500 Cartier Blvd, West, Suite 150 Laval Québec H7V 5B7 Canada Tel: +1.450.781.0115 Fax: +1.450.781.4477 Email: info ...See details»
Member profile: Liminal BioSciences | BIA - BioIndustry
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G …See details»
Liminal BioSciences Inc. - AnnualReports.com
Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis.See details»
LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF …
Sep 26, 2023 Organization Profile. Liminal BioSciences Inc. Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in discovering, developing and ...See details»
Liminal BioSciences Announces Strategic Priorities For 2022
Jan 19, 2022 Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in discovering, developing and commercializing novel small …See details»
Our Values - Liminal BioSciences
Balance of intellectual quotient and emotional quotient; Leverage our collective knowledge and passion; Recognition and celebration of achievementsSee details»
Liminal BioSciences - Overview, News & Similar companies
Sep 26, 2023 LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP LAVAL, QC and CAMBRIDGE, England, …See details»
Liminal BioSciences - LinkedIn
Liminal BioSciences | 8,041 followers on LinkedIn. Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive …See details»
Liminal Biosciences - Amorchem
Liminal Biosciences. Liminal Biosciences Inc. (www.liminalbiosciences.com) is a preclinical-stage biopharmaceutical company that recently acquired AmorChem’s spin-out company Fairhaven …See details»
Liminal BioSciences Announces FDA Approval for its Biologics …
Jun 4, 2021 Organization Profile. Liminal BioSciences Inc. Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in …See details»
Our Strategy - Liminal BioSciences
Inspired by the opportunity to impact lives, we are committed to excellence, innovation, and scientific rigor in the high-quality research and clinical development of novel medicines to …See details»
Liminal BioSciences Reports First Quarter Financial Results 2023
May 9, 2023 Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in discovering, developing and commercializing novel small …See details»
Liminal BioSciences - Careers
© 2023 Liminal BioSciences Inc. All Rights Reserved. | Legal Disclaimer | Privacy Policy | Cookie Policy | Social Media GuidelinesSee details»
Liminal BioSciences Announces Arrangement Agreement with …
Jul 12, 2023 Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in discovering, developing and commercializing novel small …See details»
Pipeline - Liminal BioSciences
At Liminal, we are focused on elucidating compelling biological mechanisms and advancing a pipeline of small molecule therapeutics with best-in-class potential across a broad range of …See details»